Antisense oligonucleotides inhibit vascular endothelial growth factor/vascular permeability factor expression in normal human epidermal keratinocytes

Journal of Investigative Dermatology

Volumn 108, Issue 4, 1997, Pages 523-526

  Smyth, Adrienne P ^a   Rook, Susan L ^a   Detmar, Michael ^b   Robinson, Gregory S ^a  

^a HYBRIDON INC   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; TRANSFORMING GROWTH FACTOR ALPHA; VASCULOTROPIN;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; PSORIASIS;

EID: 0030890741     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/1523-1747.ep12289740     Document Type: Article

References (20)

1. Ballaun C, Weninger W, Uthman A, Weich H, Tschachler E: Human keratinocytes express the three major splice forms of vascular endothelial growth factor. J Invest Dermatol 104:7-10, 1995
2. Brown LF, Harrist TJ, Yen K-T, Stähle-Bäckdahl M, Jackman KW, Berse B, Tognazzi K, Dvorak HF, Detmar M: Increased expression of vascular permeability factor (vascular endothelial growth factor) in bullous pemphigoid, dermatitis herpetiformis, and erythema multiforme. J Invest Dermatol 104:744-749, 1995a
3. Brown LF, Olbricht SM, Berse B, Jackman RW, Matsueda G, Tognazzi KA, Manseau EJ, Dvorak HF, Van De Water L: Overexpression of vascular permeability factor (VPF/VEGF) and its endothelial cell receptors in delayed hypersensitivity skin reactions. J Immunol 154:2801-2807, 1995b
4. Chomczynski P, Makey K: One-hour downward capillary blotting of RNA at neutral pH. Anal Biochem 221:303-305, 1994
5. Detmar M, Brown LF, Claffey KP, Yeo K-T, Kocher O, Jackman RW, Berse B, Dvorak HF: Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J Exp Med 180:1141-1146, 1994
6. Detmar M, Yeo K-T, Nagy JA, Van De Water L, Brown LF, Berse B, Elicker BM, Ledbetter S, Dvorak HF: Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells. J Invest Dermatol 105:44-50, 1995
7. Detmar M: Molecular regulation of angiogenesis in the skin. J Invest Dermatol 106:207-208, 1996.
8. de Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT: The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255: 989-991, 1992
9. Elder JT, Fisher GJ, Lindquist PB, Benett GL, Pittelkow MR, Coffey RJ, Ellingsworth L, Derynck R, Voorhees JJ: Overexpression of transforming growth factor alpha in psoriatic epidermis. Science 243:811-814, 1989
10. Ferrara N, Houck KA, Jakeman LB, Winer J, Leung DW: The vascular endothelial growth factor family of polypeptides. J Cell Biochem 47:211-218, 1991
11. Field AK, Goodchild J: Antisense oligonucleotides: Rational drug design for genetic pharmacology. Exp Opin Invest Drugs 4(9):799-821, 1995
12. Hertl M, Neckers LM, Katz SI: Inhibition of interferon-γ-induced intercellular adhesion molecule-1 expression on human keratinocytes by phosphorothioate antisense oligodeoxynucleotides is the consquence of antisense-specific and antisense-non-specific effects. J Invest Dermatol 104:813-818, 1995
13. Masiakowski P, Breathnach R, Bloch J, Gannon F, Krust A, Chambon P: Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line. Nucleic Acids Res 10:7895-7903, 1982
14. Mirabelli C, Cronke ST: Antisense oligonucleotides in the context of modern molecular drug discovery and development. In: Crooke ST, Lebleu B (eds.). Antisense Research and Applications. 7-35, CRC, Boca Raton, FL, 1993
15. Park JE, Keller G-A, Ferrara N: The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol Biol Cell 4:1317-1326, 1993
16. Robinson GS, Pierce EA, Rook SL, Foley E, Webb R, Smith LEH: Oligonucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy. Proc Natl Acad Sci USA 93:4851-4856, 1996
17. Shima DT, Gougos A, Miller JW, Tolentino M, Robinson G, Adamis AP, D'Amore PA: Cloning and mRNA expression of vascular endothelial growth factor in ischemic retinas of Macaca fascicularis. Invest Opthalmol Visual Sci 37(7):1334-1340, 1996
18. Terman, BI, Dougher VM, Carrion ME, Dimitrov D, Armellino DC, Gospodarowicz D, Bohlen P: Identification of the KDR tyrosine kinase as a receptor for vascular endothelial growth factor. Biochem Biophys Res Commun 187:1579-1586, 1992
19. Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC, Abraham JA: The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 266:11947-11954, 1991
20. Watts P, Stables GS, Akhurst RJ, MacKie RM: Localization of transforming growth factor-alpha RNA and protein in the skin of psoriatic patients recieving therapy. Br J Dermatol 131:64-71, 1994